Sun Pharma
Sun Pharma

New Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore for the quarter ended December 31, 2019.

The company had posted a net profit of Rs 1,241.85 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.

Consolidated income from operations of the company stood at Rs 8,038.65 crore for the quarter under consideration. It was Rs 7,656.71 crore for the same period a year ago. The company's board has declared an interim dividend of Rs 3 per equity share of Re 1 each, Sun Pharma said.

Shares of Sun Pharmaceutical Industries closed at Rs 430.95 per scrip on the BSE, up 1.13 per cent from its previous close.

(For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)

Free Press Journal